首页 > 最新文献

World Journal of OtorhinolaryngologyHead and Neck Surgery最新文献

英文 中文
A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials. 鼻咽癌临床试验的全面回顾和特征描述。
Q2 Medicine Pub Date : 2022-09-30 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.80
Katherine Xu, Emma De Ravin, Neeraj Suresh, Robert M Brody, Karthik Rajasekaran

Objective: Although standard of care for primary nasopharyngeal carcinoma (NPC) is chemoradiotherapy, there remains no consensus on management of recurrent or metastatic disease. We characterized recent clinical trials on NPC to assess trends in NPC treatment and establish promising areas for future research.

Study design: Retrospective database study.

Setting: ClinicalTrials.gov database.

Methods: Retrospective review of all NPC trials from November 1999 to June 2021. For each study, the following variables were extracted: study characteristics, intervention, outcome measures, and inclusion criteria. Secondary searches via PubMed and Google scholar determined trial publication status.

Results: A total of 448 clinical trials were identified: 72 (16%) observational and 376 (84%) interventional, of which there were 30 (8%) Phase I, 183 (49%) Phase II, 86 Phase III (23%), and 5 (1%) Phase IV trials. Fifty-four percent of trials included only primary NPC while 111 (25%) exclusively studied recurrent cancers. The most common interventions were cisplatin (n = 64) and intensity modulated radiation therapy (n = 54); there were 38 trials involving PD-1 monoclonal antibodies. Thirty-four studies examined quality of life measures, including xerostomia and mucositis. Of the completed studies, 53.2% have published manuscripts. Poor patient accrual was the most common reason for premature study termination.

Conclusions: Novel immunotherapies have been increasingly incorporated into NPC studies in recent years, however, chemotherapy and radiation, despite their numerous side effects, are still widely used due to their clinical effectiveness. Future trials are warranted to determine the optimal therapeutic regimens to decrease relapse rates and side effects.

目的:虽然原发性鼻咽癌(NPC)的标准治疗方法是放化疗,但对于复发或转移性疾病的治疗仍未达成共识。我们对近期的鼻咽癌临床试验进行了特征分析,以评估鼻咽癌治疗的趋势,并确定未来有希望的研究领域:研究设计:回顾性数据库研究:研究设计:回顾性数据库研究:方法:回顾性审查 1999 年 11 月至 2021 年 6 月期间的所有鼻咽癌试验。对每项研究提取以下变量:研究特征、干预措施、结果测量和纳入标准。通过 PubMed 和 Google scholar 进行二次检索,确定试验的发表状态:结果:共发现 448 项临床试验:72项(16%)观察性试验和376项(84%)干预性试验,其中I期试验30项(8%),II期试验183项(49%),III期试验86项(23%),IV期试验5项(1%)。54%的试验只包括原发性鼻咽癌,111项(25%)专门研究复发性癌症。最常见的干预措施是顺铂(64 例)和强度调节放射治疗(54 例);有 38 项试验涉及 PD-1 单克隆抗体。34项研究对生活质量进行了检测,包括口腔干燥症和粘膜炎。在已完成的研究中,53.2%的研究发表了手稿。患者应征不足是研究过早终止的最常见原因:结论:近年来,新型免疫疗法越来越多地被纳入鼻咽癌研究,然而,尽管化疗和放疗有很多副作用,但由于其临床疗效显著,仍被广泛使用。未来有必要进行试验,以确定最佳治疗方案,降低复发率和副作用。
{"title":"A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials.","authors":"Katherine Xu, Emma De Ravin, Neeraj Suresh, Robert M Brody, Karthik Rajasekaran","doi":"10.1002/wjo2.80","DOIUrl":"10.1002/wjo2.80","url":null,"abstract":"<p><strong>Objective: </strong>Although standard of care for primary nasopharyngeal carcinoma (NPC) is chemoradiotherapy, there remains no consensus on management of recurrent or metastatic disease. We characterized recent clinical trials on NPC to assess trends in NPC treatment and establish promising areas for future research.</p><p><strong>Study design: </strong>Retrospective database study.</p><p><strong>Setting: </strong>ClinicalTrials.gov database.</p><p><strong>Methods: </strong>Retrospective review of all NPC trials from November 1999 to June 2021. For each study, the following variables were extracted: study characteristics, intervention, outcome measures, and inclusion criteria. Secondary searches via PubMed and Google scholar determined trial publication status.</p><p><strong>Results: </strong>A total of 448 clinical trials were identified: 72 (16%) observational and 376 (84%) interventional, of which there were 30 (8%) Phase I, 183 (49%) Phase II, 86 Phase III (23%), and 5 (1%) Phase IV trials. Fifty-four percent of trials included only primary NPC while 111 (25%) exclusively studied recurrent cancers. The most common interventions were cisplatin (<i>n</i> = 64) and intensity modulated radiation therapy (<i>n</i> = 54); there were 38 trials involving PD-1 monoclonal antibodies. Thirty-four studies examined quality of life measures, including xerostomia and mucositis. Of the completed studies, 53.2% have published manuscripts. Poor patient accrual was the most common reason for premature study termination.</p><p><strong>Conclusions: </strong>Novel immunotherapies have been increasingly incorporated into NPC studies in recent years, however, chemotherapy and radiation, despite their numerous side effects, are still widely used due to their clinical effectiveness. Future trials are warranted to determine the optimal therapeutic regimens to decrease relapse rates and side effects.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"174-182"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/aa/WJO2-9-174.PMC10296046.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of facial dog bite trauma: A contemporary perspective and review. 狗咬伤面部创伤的手术治疗:当代视角与回顾。
Q2 Medicine Pub Date : 2022-09-26 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.75
Tiffany Chen, Maria Karim, Zachary T Grace, Andrew R Magdich, Eric C Carniol, Brian E Benson, Peter F Svider

Objective: To perform a review evaluating management of and complications stemming from dog bite trauma sustained to the head and neck over the past decade.

Data sources: PubMed and Cochrane Library.

Methods: The authors searched the PubMed and Cochrane Library databases for relevant published literature. A total of 12 peer-reviewed canine-exclusive series inclusive of 1384 patient cases describing facial dog bite trauma met inclusion criteria. Wounds including fractures, lacerations, contusions, and other soft-tissue injuries were evaluated. Demographics related to clinical course and management, operating room requirements, and antibiotic usage were compiled and analyzed. Initial trauma and surgical management complications were also assessed.

Results: 75.5% of patients sustaining dog bites required surgical intervention. Of these patients, 7.8% suffered from postsurgical complications, including hypertrophic scarring (4.3%), postoperative infection (0.8%), or nerve deficits and persistent paresthesias (0.8%). Prophylactic antibiotics were administered to 44.3% of patients treated for facial dog bites and the overall infection rate was 5.6%. Concomitant fracture was present in 1.0% of patients.

Conclusion: Primary closure, often in the OR may be necessary, with few cases requiring grafts or flaps. Surgeons should be aware that the most common complication is hypertrophic scarring. Further research is needed to elucidate the role of prophylactic antibiotics.

目的对过去十年中被狗咬伤的头颈部外伤的处理和并发症进行回顾性评估:数据来源:PubMed 和 Cochrane 图书馆:作者在 PubMed 和 Cochrane 图书馆数据库中搜索了相关的已发表文献。符合纳入标准的同行评议犬类系列文献共有 12 篇,包括 1384 个描述面部被狗咬伤创伤的患者病例。对包括骨折、撕裂伤、挫伤和其他软组织损伤在内的伤口进行了评估。对与临床过程和处理、手术室需求和抗生素使用相关的人口统计学数据进行了整理和分析。此外,还对最初的创伤和手术治疗并发症进行了评估:75.5%的被狗咬伤患者需要接受手术治疗。结果:75.5%的被狗咬伤患者需要接受手术治疗,其中7.8%的患者出现术后并发症,包括增生性疤痕(4.3%)、术后感染(0.8%)、神经功能缺损和持续性麻痹(0.8%)。44.3%的面部被狗咬伤患者接受了预防性抗生素治疗,总体感染率为5.6%。1.0%的患者伴有骨折:结论:初次闭合可能是必要的,通常在手术室进行,需要移植物或皮瓣的病例很少。外科医生应注意,最常见的并发症是增生性瘢痕。需要进一步研究以阐明预防性抗生素的作用。
{"title":"Surgical management of facial dog bite trauma: A contemporary perspective and review.","authors":"Tiffany Chen, Maria Karim, Zachary T Grace, Andrew R Magdich, Eric C Carniol, Brian E Benson, Peter F Svider","doi":"10.1002/wjo2.75","DOIUrl":"10.1002/wjo2.75","url":null,"abstract":"<p><strong>Objective: </strong>To perform a review evaluating management of and complications stemming from dog bite trauma sustained to the head and neck over the past decade.</p><p><strong>Data sources: </strong>PubMed and Cochrane Library.</p><p><strong>Methods: </strong>The authors searched the PubMed and Cochrane Library databases for relevant published literature. A total of 12 peer-reviewed canine-exclusive series inclusive of 1384 patient cases describing facial dog bite trauma met inclusion criteria. Wounds including fractures, lacerations, contusions, and other soft-tissue injuries were evaluated. Demographics related to clinical course and management, operating room requirements, and antibiotic usage were compiled and analyzed. Initial trauma and surgical management complications were also assessed.</p><p><strong>Results: </strong>75.5% of patients sustaining dog bites required surgical intervention. Of these patients, 7.8% suffered from postsurgical complications, including hypertrophic scarring (4.3%), postoperative infection (0.8%), or nerve deficits and persistent paresthesias (0.8%). Prophylactic antibiotics were administered to 44.3% of patients treated for facial dog bites and the overall infection rate was 5.6%. Concomitant fracture was present in 1.0% of patients.</p><p><strong>Conclusion: </strong>Primary closure, often in the OR may be necessary, with few cases requiring grafts or flaps. Surgeons should be aware that the most common complication is hypertrophic scarring. Further research is needed to elucidate the role of prophylactic antibiotics.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"123-130"},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/aa/WJO2-9-123.PMC10296040.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Guidelines. 作者指导方针。
Q2 Medicine Pub Date : 2022-09-16 eCollection Date: 2022-09-01 DOI: 10.1002/wjo2.76
{"title":"Author Guidelines.","authors":"","doi":"10.1002/wjo2.76","DOIUrl":"https://doi.org/10.1002/wjo2.76","url":null,"abstract":"","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":" ","pages":"279-286"},"PeriodicalIF":0.0,"publicationDate":"2022-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479473/pdf/WJO2-8-279.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33485073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations. 用于检测复发性鼻咽癌的监测工具:基于证据的回顾和建议。
Q2 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.wjorl.2020.12.002
Andrew Thamboo, Kim H Tran, Annette X Ye, Issraa Shoucair, Basel Jabarin, Eitan Prisman, Cathie Garnis

Objective: Nasopharyngeal carcinomas (NPC) are tumors arising from epithelium of the nasopharynx. The 5-year survival rate of primary NPC is 80% with significant risks of recurrence. The objective here is to provide an evidence-based systemic review of the diagnostic value of different modalities in detecting local, regional, and distal recurrent NPC, as well as the associated costs with these modalities.

Methods: MEDLINE, EMBASE, and the Cochrane review database were queried. Two hundred and twenty-three abstracts were generated using the inclusion criteria: patients >18 years of age; histopathological reference standard; and modalities pertaining to imaging or microbiology.

Results: Twenty-four manuscripts fulfilled the inclusion criteria and 5 surveillance tools identified: endoscopy, MR, FDG-PET, Tc-99m MIBI and 201TI SPECT, and EBV DNA.

Conclusions: For local surveillance, endoscopy is the gold standard recommendation, with increased efficacy if Narrow Band Imaging or contact endoscopy are utilized. MRI and FDG-PET is also recommended to help with local to distal spread; however, Tc-99m MIBI and 201TI SPECT are options as well. EBV DNA is recommended as a cheap and accessible adjunct surveillance tool if an available as an option.

目的:鼻咽癌是发生于鼻咽上皮的肿瘤。原发性鼻咽癌的5年生存率为80%,有明显的复发风险。本文的目的是对不同方式在检测局部、区域和远端复发性鼻咽癌中的诊断价值,以及与这些方式相关的成本,提供基于证据的系统综述。方法:对MEDLINE、EMBASE和Cochrane综述数据库进行查询。采用纳入标准生成223篇摘要:患者>18岁;组织病理学参考标准;以及与成像或微生物学有关的模式。结果:24篇文章符合纳入标准,并确定了5种监测工具:内镜、MR、FDG-PET、Tc-99m MIBI和201TI SPECT,以及EBV DNA。结论:对于局部监测,内窥镜检查是金标准推荐,如果使用窄带成像或接触式内窥镜检查,其疗效会提高。MRI和FDG-PET也被推荐用于帮助局部到远端扩散;然而,Tc-99m MIBI和201TI SPECT也是选项。如果可以作为一种选择,建议将EBV DNA作为一种廉价和可获得的辅助监测工具。
{"title":"Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations.","authors":"Andrew Thamboo,&nbsp;Kim H Tran,&nbsp;Annette X Ye,&nbsp;Issraa Shoucair,&nbsp;Basel Jabarin,&nbsp;Eitan Prisman,&nbsp;Cathie Garnis","doi":"10.1016/j.wjorl.2020.12.002","DOIUrl":"https://doi.org/10.1016/j.wjorl.2020.12.002","url":null,"abstract":"<p><strong>Objective: </strong>Nasopharyngeal carcinomas (NPC) are tumors arising from epithelium of the nasopharynx. The 5-year survival rate of primary NPC is 80% with significant risks of recurrence. The objective here is to provide an evidence-based systemic review of the diagnostic value of different modalities in detecting local, regional, and distal recurrent NPC, as well as the associated costs with these modalities.</p><p><strong>Methods: </strong>MEDLINE, EMBASE, and the Cochrane review database were queried. Two hundred and twenty-three abstracts were generated using the inclusion criteria: patients >18 years of age; histopathological reference standard; and modalities pertaining to imaging or microbiology.</p><p><strong>Results: </strong>Twenty-four manuscripts fulfilled the inclusion criteria and 5 surveillance tools identified: endoscopy, MR, FDG-PET, Tc-99m MIBI and <sup>201</sup>TI SPECT, and EBV DNA.</p><p><strong>Conclusions: </strong>For local surveillance, endoscopy is the gold standard recommendation, with increased efficacy if Narrow Band Imaging or contact endoscopy are utilized. MRI and FDG-PET is also recommended to help with local to distal spread; however, Tc-99m MIBI and <sup>201</sup>TI SPECT are options as well. EBV DNA is recommended as a cheap and accessible adjunct surveillance tool if an available as an option.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"8 3","pages":"187-204"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.wjorl.2020.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9211146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financial impact of the COVID-19 pandemic on an academic otolaryngology department. COVID-19 大流行对耳鼻喉科学术部门的财务影响。
Q2 Medicine Pub Date : 2022-07-21 DOI: 10.1002/wjo2.51
Christina M Yver, Tiffany N Chao, Erica R Thaler, Michael J Ruckenstein, Ara A Chalian, Gregory S Weinstein, Bert W O'Malley, Steven B Cannady

Objective: To quantify the financial impact of the coronavirus disease (COVID-19) pandemic on an academic otolaryngology department.

Methods: A year-over-year comparison was used to compare department revenue from April 2020 and April 2021 as a percentage of baseline April 2019 activity.

Results: At the onset of the COVID-19 pandemic in April 2020, total department charges decreased by 83.4%, of which outpatient clinic charges were affected to the greatest extent. One year into pandemic recovery, department charges remained down 6.7% from baseline, and outpatient clinic charges remained down 9.9%. The reduction in outpatient clinic charges was mostly driven by a decrease in in-office procedure charges.

Conclusion: Given that precautions to mitigate the risk of viral transmission in the health care setting are likely to be long-lived, it is important to consider the vulnerabilities of our specialty to mitigate financial losses going forward.

目的量化冠状病毒病(COVID-19)大流行对耳鼻喉科学术部门的财务影响:方法:采用逐年比较的方法,比较 2020 年 4 月和 2021 年 4 月的科室收入占 2019 年 4 月基线活动的百分比:结果:在 2020 年 4 月 COVID-19 大流行开始时,科室总收入减少了 83.4%,其中门诊收入受到的影响最大。大流行恢复一年后,科室收费仍比基线下降 6.7%,门诊收费仍下降 9.9%。门诊收费下降的主要原因是诊室手术收费的下降:鉴于在医疗环境中降低病毒传播风险的预防措施可能会长期存在,因此必须考虑本专业的薄弱环节,以减少未来的经济损失。
{"title":"Financial impact of the COVID-19 pandemic on an academic otolaryngology department.","authors":"Christina M Yver, Tiffany N Chao, Erica R Thaler, Michael J Ruckenstein, Ara A Chalian, Gregory S Weinstein, Bert W O'Malley, Steven B Cannady","doi":"10.1002/wjo2.51","DOIUrl":"10.1002/wjo2.51","url":null,"abstract":"<p><strong>Objective: </strong>To quantify the financial impact of the coronavirus disease (COVID-19) pandemic on an academic otolaryngology department.</p><p><strong>Methods: </strong>A year-over-year comparison was used to compare department revenue from April 2020 and April 2021 as a percentage of baseline April 2019 activity.</p><p><strong>Results: </strong>At the onset of the COVID-19 pandemic in April 2020, total department charges decreased by 83.4%, of which outpatient clinic charges were affected to the greatest extent. One year into pandemic recovery, department charges remained down 6.7% from baseline, and outpatient clinic charges remained down 9.9%. The reduction in outpatient clinic charges was mostly driven by a decrease in in-office procedure charges.</p><p><strong>Conclusion: </strong>Given that precautions to mitigate the risk of viral transmission in the health care setting are likely to be long-lived, it is important to consider the vulnerabilities of our specialty to mitigate financial losses going forward.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349602/pdf/WJO2-9999-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients. 光生物调节疗法在治疗局部晚期头颈部癌症患者过程中限制口腔黏膜炎的Ⅱ期前瞻性试验。
Q2 Medicine Pub Date : 2022-07-14 eCollection Date: 2022-12-01 DOI: 10.1002/wjo2.18
Janielle K-A Taylor, Leila J Mady, Khalil Baddour, Uzoma K Iheagwara, Shuyan Zhai, James P Ohr, Daniel P Zandberg, Vikram C Gorantla, Robert L Ferris, Seungwon Kim, Umamaheswar Duvvuri, Mark W Kubik, Shaum Sridharan, Jonas T Johnson, Karen D Holeva, Annette E Quinn, David A Clump

Objective: This study aimed to compare the historical incidence rate of severe oral mucositis (OM) in head and neck cancer patients undergoing definitive concurrent chemoradiation therapy (CRT) versus a prospective cohort of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with prophylactic photobiomodulation therapy (PBMT).

Methods: This US-based, institutional, single-arm, phase Ⅱ prospective clinical trial was initiated in 50 patients (age ≥ 18 years, Karnofsky Performance Scale Index > 60, with locally advanced HNSCC (excluding oral cavity) receiving definitive or adjuvant radiation therapy (RT) with concurrent platinum-based chemotherapy (CT). PBMT was delivered three times per week throughout RT utilizing both an intraoral as well extraoral delivery system. Primary outcome measure was incidence of severe OM utilizing both the National Cancer Institute Common Toxicity Criteria, version 4.0 (NCI-CTCAE) Grade ≥3 and the World Health Organization Mucositis Grading Scale (WHO) Grade ≥3 versus historical controls; secondary outcome measures included time to onset of severe OM following therapy initiation.

Results: At baseline, all patients included in final analysis (N = 47) had OM Grade 0. Average RT and CT dose was (66.3 ± 5.1) Gy and (486.1 ± 106.8) mg/m2, respectively. Severe OM was observed in 11 of 47 patients (23%, confidence interval: 12, 38). OM toxicity grade trended upward during treatment, reaching a maximum at 7 weeks (WHO: 1.8 vs. NCI-CTCAE: 1.7). Subsequently, OM grade returned to baseline 3 months following completion of RT. The mean time to onset of severe OM was (35 ± 12) days. The mean time to resolution of severe OM was (37 ± 37) days.

Conclusions: Compared to historical outcomes, PBMT aides in decreasing severe OM in patients with locally advanced HNSCC. PBMT represents a minimally invasive, prophylactic intervention to decrease OM as a major treatment-related side effect.

研究目的本研究旨在比较头颈部癌症患者接受确定性同期化疗(CRT)与接受预防性光生物调节疗法(PBMT)治疗的局部晚期头颈部鳞状细胞癌(HNSCC)患者严重口腔黏膜炎(OM)的历史发病率:这项基于美国机构的单臂Ⅱ期前瞻性临床试验在 50 名局部晚期 HNSCC(不包括口腔)患者(年龄≥ 18 岁,Karnofsky 表征指数大于 60,接受确定性或辅助性放疗(RT)并同时接受铂类化疗(CT))中启动。在整个 RT 过程中,利用口内和口外给药系统每周进行三次 PBMT 给药。主要结局指标是与历史对照组相比,采用美国国立癌症研究所通用毒性标准 4.0 版(NCI-CTCAE)≥3 级和世界卫生组织黏膜炎分级表(WHO)≥3 级的严重 OM 发生率;次要结局指标包括治疗开始后严重 OM 的发生时间:基线时,所有纳入最终分析的患者(N = 47)的OM均为0级。平均 RT 和 CT 剂量分别为 (66.3 ± 5.1) Gy 和 (486.1 ± 106.8) mg/m2。47 例患者中有 11 例(23%,置信区间:12,38)出现严重 OM。OM毒性等级在治疗期间呈上升趋势,7周时达到最高值(WHO:1.8,NCI-CTCAE:1.7)。随后,OM 等级在 RT 结束后 3 个月恢复到基线。严重 OM 的平均发病时间为(35 ± 12)天。严重OM的平均缓解时间为(37±37)天:结论:与历史结果相比,PBMT有助于减少局部晚期HNSCC患者的严重OM。PBMT是一种微创、预防性干预措施,可减少OM这一与治疗相关的主要副作用。
{"title":"A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.","authors":"Janielle K-A Taylor, Leila J Mady, Khalil Baddour, Uzoma K Iheagwara, Shuyan Zhai, James P Ohr, Daniel P Zandberg, Vikram C Gorantla, Robert L Ferris, Seungwon Kim, Umamaheswar Duvvuri, Mark W Kubik, Shaum Sridharan, Jonas T Johnson, Karen D Holeva, Annette E Quinn, David A Clump","doi":"10.1002/wjo2.18","DOIUrl":"10.1002/wjo2.18","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the historical incidence rate of severe oral mucositis (OM) in head and neck cancer patients undergoing definitive concurrent chemoradiation therapy (CRT) versus a prospective cohort of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with prophylactic photobiomodulation therapy (PBMT).</p><p><strong>Methods: </strong>This US-based, institutional, single-arm, phase Ⅱ prospective clinical trial was initiated in 50 patients (age ≥ 18 years, Karnofsky Performance Scale Index > 60, with locally advanced HNSCC (excluding oral cavity) receiving definitive or adjuvant radiation therapy (RT) with concurrent platinum-based chemotherapy (CT). PBMT was delivered three times per week throughout RT utilizing both an intraoral as well extraoral delivery system. Primary outcome measure was incidence of severe OM utilizing both the National Cancer Institute Common Toxicity Criteria, version 4.0 (NCI-CTCAE) Grade ≥3 and the World Health Organization Mucositis Grading Scale (WHO) Grade ≥3 versus historical controls; secondary outcome measures included time to onset of severe OM following therapy initiation.</p><p><strong>Results: </strong>At baseline, all patients included in final analysis (<i>N</i> = 47) had OM Grade 0. Average RT and CT dose was (66.3 ± 5.1) Gy and (486.1 ± 106.8) mg/m<sup>2</sup>, respectively. Severe OM was observed in 11 of 47 patients (23%, confidence interval: 12, 38). OM toxicity grade trended upward during treatment, reaching a maximum at 7 weeks (WHO: 1.8 vs. NCI-CTCAE: 1.7). Subsequently, OM grade returned to baseline 3 months following completion of RT. The mean time to onset of severe OM was (35 ± 12) days. The mean time to resolution of severe OM was (37 ± 37) days.</p><p><strong>Conclusions: </strong>Compared to historical outcomes, PBMT aides in decreasing severe OM in patients with locally advanced HNSCC. PBMT represents a minimally invasive, prophylactic intervention to decrease OM as a major treatment-related side effect.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"8 4","pages":"345-354"},"PeriodicalIF":0.0,"publicationDate":"2022-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/3d/WJO2-8-345.PMC9714046.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Guidelines. 作者指导方针。
Q2 Medicine Pub Date : 2022-06-29 eCollection Date: 2022-06-01 DOI: 10.1002/wjo2.74
{"title":"Author Guidelines.","authors":"","doi":"10.1002/wjo2.74","DOIUrl":"https://doi.org/10.1002/wjo2.74","url":null,"abstract":"","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"8 2","pages":"167-174"},"PeriodicalIF":0.0,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242414/pdf/WJO2-8-167.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40558873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender analysis of the top classic papers in otolaryngology head and neck surgery. 耳鼻咽喉头颈外科顶级经典论文的性别分析。
Q2 Medicine Pub Date : 2022-06-22 eCollection Date: 2023-06-01 DOI: 10.1002/wjo2.68
Beatrice Go, Neeraj Suresh, Cammille Go, Kevin Chorath, Natasha Mirza, Erica Thaler, Alvaro Moreira, Karthik Rajasekaran

Objective: The aim of this study was to identify and analyze the gender breakdown of first authorship contributing to the most-cited papers in the field of otolaryngology, with a goal of identifying trends in gender representation in publishing.

Methods: The top 150 most-cited papers were identified using the Science Citation Index of the Institute for Scientific Information. Among the first authors, gender, h-index, percentage of first, last, and corresponding authorship positions, total publications, and citations were analyzed.

Results: The majority of papers were in the English language, from the United States, of clinical nature, and on otologic topics. Eighty-one percent of papers (n = 122) had men who were first authors, although there was no difference in h-index score, authorship position, number of publications, citations, and average citations/year between men and women first authors. Upon subgroup analysis by decade (1950s-2010s), there was no difference in the number of articles by women first authors (P = 0.11); however, there was a statistically significant increase in the percentage of women authors (P = 0.001) in papers published later compared to those published earlier.

Conclusions: While a promising number of women otolaryngologists are publishing high-powered articles, future initiatives to promote academic inclusivity of women should be considered.

研究目的本研究旨在确定和分析耳鼻喉科领域被引用次数最多的论文的第一作者的性别分布情况,从而确定发表论文中的性别比例趋势:方法:利用科学信息研究所的科学引文索引确定了被引用次数最多的 150 篇论文。分析了第一作者的性别、h 指数、第一作者、最后作者和通讯作者的百分比、发表论文总数和引用次数:大部分论文为英文,来自美国,属于临床性质,主题为耳科。81%的论文(n = 122)的第一作者为男性,但男性和女性第一作者在 h 指数得分、作者位置、发表论文数量、引用次数和平均引用次数/年方面没有差异。按年代(20 世纪 50 年代至 2010 年代)进行分组分析后,女性第一作者的文章数量没有差异(P = 0.11);然而,与较早发表的论文相比,较晚发表的论文中女性作者的比例有显著增加(P = 0.001):结论:虽然耳鼻喉科女医师发表高水平文章的数量很可观,但今后应考虑采取举措,促进学术界对女性的包容。
{"title":"Gender analysis of the top classic papers in otolaryngology head and neck surgery.","authors":"Beatrice Go, Neeraj Suresh, Cammille Go, Kevin Chorath, Natasha Mirza, Erica Thaler, Alvaro Moreira, Karthik Rajasekaran","doi":"10.1002/wjo2.68","DOIUrl":"10.1002/wjo2.68","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to identify and analyze the gender breakdown of first authorship contributing to the most-cited papers in the field of otolaryngology, with a goal of identifying trends in gender representation in publishing.</p><p><strong>Methods: </strong>The top 150 most-cited papers were identified using the Science Citation Index of the Institute for Scientific Information. Among the first authors, gender, <i>h</i>-index, percentage of first, last, and corresponding authorship positions, total publications, and citations were analyzed.</p><p><strong>Results: </strong>The majority of papers were in the English language, from the United States, of clinical nature, and on otologic topics. Eighty-one percent of papers (<i>n</i> = 122) had men who were first authors, although there was no difference in <i>h</i>-index score, authorship position, number of publications, citations, and average citations/year between men and women first authors. Upon subgroup analysis by decade (1950s-2010s), there was no difference in the number of articles by women first authors (<i>P</i> = 0.11); however, there was a statistically significant increase in the percentage of women authors (<i>P</i> = 0.001) in papers published later compared to those published earlier.</p><p><strong>Conclusions: </strong>While a promising number of women otolaryngologists are publishing high-powered articles, future initiatives to promote academic inclusivity of women should be considered.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"160-167"},"PeriodicalIF":0.0,"publicationDate":"2022-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/62/WJO2-9-160.PMC10296043.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tinnitus assessment: Chinese version of the Tinnitus Primary Function Questionnaire. 耳鸣评估:中文版耳鸣初级功能问卷。
Q2 Medicine Pub Date : 2022-06-17 eCollection Date: 2023-03-01 DOI: 10.1002/wjo2.60
Ying Xin, Richard Tyler, Zi-Ming Yao, Na Zhou, Shan Xiong, Li-Yuan Tao, Fu-Rong Ma, Tao Pan

Objective: The aim of this study is to evaluate the Chinese Version of the Tinnitus Primary Function Questionnaire (TPFQ).

Methods: One hundred and sixteen patients who had been suffering from tinnitus for over 3 months were included in this study. Those tinnitus patients were administered the TPFQ, the Tinnitus Handicap Inventory (THI), the Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), and the Pittsburgh Sleep Quality Index (PSQI). Additionally, the magnitude estimate of tinnitus loudness, pure tone audiogram, and tinnitus matching was obtained. The factor structure was measured using the Kaiser-Meyer-Olkin test. The internal consistency was examined using Cronbach's α coefficient. The relationships between the TPFQ scores and other measurements were compared using Spearman's rank correlation coefficient.

Results: The Cronbach's α of the 20-item version of TPFQ was 0.94, and that of the 12-item version of TPFQ was 0.92. Both the 20- and 12-item versions of TPFQ were significantly correlated with magnitude estimation of tinnitus loudness, THI, PSQI, BDI, and BAI. The average pure tone hearing threshold was significantly correlated with the hearing subscale.

Conclusion: The 20- and 12-item Chinese versions of TPFQ are reliable and valid measures of tinnitus. The TPFQ can be applied to the assessment and management of tinnitus among the Chinese-speaking population.

目的:本研究旨在评估中文版耳鸣初级功能问卷(TPFQ):本研究旨在评估中文版耳鸣初级功能问卷(TPFQ):方法:本研究共纳入 116 名耳鸣患者,这些患者的耳鸣病程均超过 3 个月。这些耳鸣患者接受了 TPFQ、耳鸣障碍量表(THI)、贝克焦虑量表(BAI)、贝克抑郁量表(BDI)和匹兹堡睡眠质量指数(PSQI)的测试。此外,还获得了耳鸣响度的估计值、纯音听力图和耳鸣匹配度。因子结构采用 Kaiser-Meyer-Olkin 检验。内部一致性采用 Cronbach's α 系数进行检验。使用斯皮尔曼等级相关系数比较了 TPFQ 分数与其他测量指标之间的关系:结果:20 项 TPFQ 版本的 Cronbach's α 为 0.94,12 项 TPFQ 版本的 Cronbach's α 为 0.92。20项和12项版TPFQ均与耳鸣响度估计值、THI、PSQI、BDI和BAI显著相关。平均纯音听阈与听力分量表显著相关:结论:20 项和 12 项中文版 TPFQ 是可靠有效的耳鸣测量方法。结论:中文版 TPFQ 的 20 个项目和 12 个项目是可靠有效的耳鸣测量方法,可用于华语人群耳鸣的评估和管理。
{"title":"Tinnitus assessment: Chinese version of the Tinnitus Primary Function Questionnaire.","authors":"Ying Xin, Richard Tyler, Zi-Ming Yao, Na Zhou, Shan Xiong, Li-Yuan Tao, Fu-Rong Ma, Tao Pan","doi":"10.1002/wjo2.60","DOIUrl":"10.1002/wjo2.60","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to evaluate the Chinese Version of the Tinnitus Primary Function Questionnaire (TPFQ).</p><p><strong>Methods: </strong>One hundred and sixteen patients who had been suffering from tinnitus for over 3 months were included in this study. Those tinnitus patients were administered the TPFQ, the Tinnitus Handicap Inventory (THI), the Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), and the Pittsburgh Sleep Quality Index (PSQI). Additionally, the magnitude estimate of tinnitus loudness, pure tone audiogram, and tinnitus matching was obtained. The factor structure was measured using the Kaiser-Meyer-Olkin test. The internal consistency was examined using Cronbach's <i>α</i> coefficient. The relationships between the TPFQ scores and other measurements were compared using Spearman's rank correlation coefficient.</p><p><strong>Results: </strong>The Cronbach's <i>α</i> of the 20-item version of TPFQ was 0.94, and that of the 12-item version of TPFQ was 0.92. Both the 20- and 12-item versions of TPFQ were significantly correlated with magnitude estimation of tinnitus loudness, THI, PSQI, BDI, and BAI. The average pure tone hearing threshold was significantly correlated with the hearing subscale.</p><p><strong>Conclusion: </strong>The 20- and 12-item Chinese versions of TPFQ are reliable and valid measures of tinnitus. The TPFQ can be applied to the assessment and management of tinnitus among the Chinese-speaking population.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 1","pages":"27-34"},"PeriodicalIF":0.0,"publicationDate":"2022-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/3b/WJO2-9-27.PMC10050966.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9241495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal vestibular furunculosis: Summarised case series. 鼻前庭疖病:病例系列总结。
Q2 Medicine Pub Date : 2022-05-23 eCollection Date: 2022-09-01 DOI: 10.1016/j.wjorl.2020.12.003
Shirwa Sheik-Ali, Sharaf Sheik-Ali, Azizi Sheik-Ali

Objective: Nasal vestibular furunculosis (NVF) is characterized by an acute localized infection of the hair follicle in the skin lining of the nasal vestibule. This study provides an up-to-date narrative analysis on NVF, its presentation, complications and management.

Methods: A literature search was conducted electronically with no time constraints using "Nasal Vestibular Furuncolosis" or "NVF" through Medline, Cochrane Library and Web of Science, including MeSH terms with no language restrictions. Included were: Studies that described NVF's presentation and subsequent management and excluded were: Irrelevant studies that did not provide details about NVF's presentation or management, furthermore studies that alluded to Nasal vestibulitis without furunculosis were excluded. There were no limitations on time, up until the review was commenced in May 2020.

Results: Seven articles complied with the inclusion criteria. All papers reviewed were from 2015 to 2020. Three out of 4 studies reported duration of symptomatic NVF between 3 and 4 days. The most common presentation of NVF was reported as erythema, swelling, tender over the nasal tip. The most frequent, successful management of NVF frequently included intranasal topical mupirocin and in some cases oral sodium fusidate. NVF was reported to clear within 7 days by 2 studies. There were no randomised studies exploring NVF or NVF management.

Conclusion: Although a very common condition, much research is required to allude to the pathophysiology and management of NVF. Future studies should explore the reasons as to the resistance of topical antibiotics in some patients, the differing strains of staphylococcus aureus and their resulting complications, the reasons behind the familiar connection and the most effective management plan for NVF.

目的:鼻前庭毛囊炎(NVF)的特征是鼻前庭皮肤黏膜上的毛囊发生急性局部感染。本研究对 NVF 及其表现、并发症和处理方法进行了最新的叙述性分析:方法:在不受时间限制的情况下,通过 Medline、Cochrane 图书馆和 Web of Science,使用 "鼻前庭毛囊炎 "或 "NVF "进行电子文献检索,包括无语言限制的 MeSH 术语。包括描述 NVF 症状和后续治疗的研究,排除的研究包括排除:未提供 NVF 症状或治疗细节的相关研究,以及暗示鼻前庭炎而无疖病的研究。没有时间限制,直到 2020 年 5 月开始进行综述:7篇文章符合纳入标准。所有综述论文的时间均为 2015 年至 2020 年。4 项研究中有 3 项报告了无症状 NVF 的持续时间为 3 至 4 天。最常见的 NVF 表现为鼻尖红斑、肿胀和触痛。最常见、最成功的 NVF 治疗方法通常包括鼻内局部使用莫匹罗星,在某些情况下也包括口服夫西地酸钠。据两项研究报告,NVF 可在 7 天内痊愈。没有任何随机研究探讨了 NVF 或 NVF 的治疗方法:结论:虽然 NVF 是一种非常常见的疾病,但仍需开展大量研究来探讨其病理生理学和治疗方法。未来的研究应探讨部分患者对局部抗生素产生耐药性的原因、金黄色葡萄球菌的不同菌株及其导致的并发症、熟悉的联系背后的原因以及最有效的 NVF 治疗方案。
{"title":"Nasal vestibular furunculosis: Summarised case series.","authors":"Shirwa Sheik-Ali, Sharaf Sheik-Ali, Azizi Sheik-Ali","doi":"10.1016/j.wjorl.2020.12.003","DOIUrl":"10.1016/j.wjorl.2020.12.003","url":null,"abstract":"<p><strong>Objective: </strong>Nasal vestibular furunculosis (NVF) is characterized by an acute localized infection of the hair follicle in the skin lining of the nasal vestibule. This study provides an up-to-date narrative analysis on NVF, its presentation, complications and management.</p><p><strong>Methods: </strong>A literature search was conducted electronically with no time constraints using \"Nasal Vestibular Furuncolosis\" or \"NVF\" through Medline, Cochrane Library and Web of Science, including MeSH terms with no language restrictions. Included were: Studies that described NVF's presentation and subsequent management and excluded were: Irrelevant studies that did not provide details about NVF's presentation or management, furthermore studies that alluded to Nasal vestibulitis without furunculosis were excluded. There were no limitations on time, up until the review was commenced in May 2020.</p><p><strong>Results: </strong>Seven articles complied with the inclusion criteria. All papers reviewed were from 2015 to 2020. Three out of 4 studies reported duration of symptomatic NVF between 3 and 4 days. The most common presentation of NVF was reported as erythema, swelling, tender over the nasal tip. The most frequent, successful management of NVF frequently included intranasal topical mupirocin and in some cases oral sodium fusidate. NVF was reported to clear within 7 days by 2 studies. There were no randomised studies exploring NVF or NVF management.</p><p><strong>Conclusion: </strong>Although a very common condition, much research is required to allude to the pathophysiology and management of NVF. Future studies should explore the reasons as to the resistance of topical antibiotics in some patients, the differing strains of <i>staphylococcus aureus</i> and their resulting complications, the reasons behind the familiar connection and the most effective management plan for NVF.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":" ","pages":"217-223"},"PeriodicalIF":0.0,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/87/WJO2-8-217.PMC9479471.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33485072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of OtorhinolaryngologyHead and Neck Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1